Target
- ITD 1 (HB3446)Description:- Selective TGF-β signaling inhibitor. Induces cardiomyocyte differentiation in ESCs. Purity:- >98% 
- Ivermectin (IVM) (HB1958)Description:- α7 nicotinic acetylcholine receptor positive allosteric modulator. Activates GluCI/GlyCI chemogenetic channels. Shows antiviral activity. Purity:- >95% 
- IWP 2 (HB0344)Description:- Potent Wnt pathway inhibitor and PORCN inhibitor. Suppresses R1 ESC self-renewal. Used in the production of cardiac organoids. Purity:- >98% 
- Jasplakinolide (HB3946)Description:- Cell permeable, non-fluorescent F-actin probe. Induces actin polymerization and stabilization. Purity:- >98% 
- JF-NP-26 (Caged-Raseglurant) (HB6127)Description:- Novel, inactive photocaged derivative of raseglurant which can be uncaged with violet light. Shows light-dependent analgesic activity in vivo. Purity:- >98% 
- JHU37152 (DREADD ligand) (HB6252)Description:- Novel DREADD agonist with high affinity and potency for hM3Dq and hM4Di. Active in vivo. Freebase. Purity:- >98% 
- Description:Novel DREADD agonist with high affinity and potency for hM3Dq and hM4Di. Active in vivo. Water soluble. Purity:>98% 
 
  
  
  
 
 
  





